Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v13-FR | Version v4-FR | |
|---|---|---|
| Language | French | French |
| Date Updated | 2024-08-01 | 2024-03-31 |
| Drug Identification Number | 02517132 | 02517132 |
| Brand name | DEXTROSE INJECTION | DEXTROSE INJECTION |
| Common or Proper name | DEXTROSE INJECTION | DEXTROSE INJECTION |
| Company Name | OMEGA LABORATORIES LIMITED | OMEGA LABORATORIES LIMITED |
| Ingredients | DEXTROSE | DEXTROSE |
| Strength(s) | 50% | 50% |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | INTRAVENOUS | INTRAVENOUS |
| Packaging size | 10 x 50mL vial / fiole | 10 x 50mL vial / fiole |
| ATC code | B05BA | B05BA |
| ATC description | I.V. SOLUTIONS | I.V. SOLUTIONS |
| Reason for shortage | Other (Please describe in comments) | Other (Please describe in comments) |
| Anticipated start date | 2024-04-01 | 2024-04-01 |
| Actual start date | 2024-04-01 | 2024-04-01 |
| Estimated end date | 2024-08-31 | 2024-05-31 |
| Actual end date | 2024-07-31 | |
| Shortage status | Resolved | Anticipated shortage |
| Tier 3 Status | No | No |
| Company comments | Omega has made the decision to re-instate an allocation for Omega Dextrose to prevent overstocking of the Canadian labeled product. | Omega has made the decision to re-instate an allocation for Omega Dextrose to prevent overstocking of the Canadian labeled product. |
| Health Canada comments |